Mutations that occur in oncogenes, such as PI3KCA gene encoding the subunit p110, and in tumour suppressor genes, such as phosphatase and tensin homolog (PTEN), are the major mutations responsible for the dysregulation of this pathway in human tumours [13,14]. This evidence concerns the gene PTEN and neoplasm.